MC2 Therapeutics Announces Submission of New Drug Application to US FDA for Wynzora Cream (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%) for Treatment...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Sep 24, 2019--
COPENHAGEN, Denmark--(BUSINESS WIRE)--Sep 24, 2019--